Updated on 28 October 2026
Analytical Partner: UHPLC-MS/MS Profiling & Bioactivity Assessment for Health Consortia
Senior researcher at Lithuanian university of health sciences
Kaunas, Lithuania
About
Partner Expertise & Call Contribution
The Lithuanian University of Health Sciences (LSMU), Institute of Pharmaceutical Technologies, offers specialized expertise to address complex analytical and screening challenges in Horizon Europe Cluster 6 / Health consortia.
We bridge high-resolution analytical chemistry with pharmacological validation to support drug discovery, natural product development, standardized extract characterization, and safety/efficacy assessments.
Core Analytical & Research Capabilities:
-
Chromatography & Mass Spectrometry: Development and validation of UHPLC, HPLC, and LC-MS/MS methods for complex biological and botanical matrices.
-
Chemical Profiling & Quality Control: Detailed qualitative and quantitative characterization of active pharmaceutical ingredients (APIs), secondary metabolites, and target bioactive compounds.
-
In Vitro Bioactivity Screening: Cell-based and biochemical assays evaluating antioxidant, anti-inflammatory, cytotoxic, and pharmacological properties.
-
Preclinical & Formulation Support: Stability testing, extract standardization, and analytical quality control for novel therapeutic and health-related formulations.
Role in Project:
-
Work Package (WP) Leader or Partner in analytical methodology, bioactivity screening, and quality control.
-
Data interpretation and reporting compliant with European standards and open-access research practices.
Contact: Dr. Vaidotas Žvikas, LSMU Institute of Pharmaceutical Technologies.
Similar opportunities
Project cooperation
Lina Raudonė
Chief researcher, professor at Lithuanian University of Health Sciences
Kaunas, Lithuania
Project cooperation
Lithuanian university of health sciences
Lina Simenienė
International Project Manager at Lithuanian university of health sciences
Kaunas, Lithuania
Project cooperation
Clinical Trial and Academic Research Partner for Neurodegenerative Diseases
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
Andrius Ališauskas
Associate Professor, Department of Internal Medicine at Lithuanian university of health sciences
Kaunas, Lithuania